Automated on-line in-tube solid-phase microextraction coupled with HPLC/MS/MS for the determination of butyrophenone derivatives in human plasma

Analytical and Bioanalytical Chemistry

Volumn 394, Issue 4, 2009, Pages 1161-1170

  Kumazawa, Takeshi ^a   Saeki, Koichi ^b   Yanagisawa, Isao ^c   Uchigasaki, Seisaku ^d   Hasegawa, Chika ^e   Seno, Hiroshi ^f   Suzuki, Osamu ^g   Sato, Keizo ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shiseido Irica Technology Inc   (Japan)

^c SHISEIDO RESEARCH CENTER   (Japan)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Butyrophenone; HPLC; In tube SPME; MS MS

Indexed keywords

ANALYTES; BUTYROPHENONE; BUTYROPHENONES; CAPILLARY COLUMNS; COEFFICIENTS OF VARIATIONS; EXTRACTION EFFICIENCIES; FUSED-SILICA CAPILLARIES; HPLC; HPLC/MS/MS; HUMAN PLASMA SAMPLES; HUMAN PLASMAS; IN-TUBE SOLID-PHASE MICROEXTRACTION; IN-TUBE SPME; INNER SURFACES; LIMITS OF DETECTION; MOBILE PHASE; MS/MS; ONLINE METHODS; PLASMA SAMPLES; REGRESSION EQUATION; SAMPLE CLEAN-UP; SEPARATION TECHNIQUES; TANDEM MASS SPECTROMETRY;

ACETONITRILE; CHROMATOGRAPHIC ANALYSIS; COLUMN CHROMATOGRAPHY; FUSED SILICA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEIC ACIDS; PLASMA (HUMAN); PLASMAS; RNA; SILICA; TUBES (COMPONENTS);

EXTRACTION;

BUTYROPHENONE DERIVATIVE;

ARTICLE; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE MICROEXTRACTION; TANDEM MASS SPECTROMETRY; TIME;

BUTYROPHENONES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE MICROEXTRACTION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 67349162118     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-009-2774-0     Document Type: Article

References (43)

1. Baldessarini RJ, Tarazi FI (2006) In: Brunton LL, Lazo JS, Parker KL (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 461-500
2. H Tokunaga K Kudo T Imamura N Jitsufuchi T Nagata 1996 Jpn J Legal Med 50 196 202
3. IM McIntyre CV King V Staikos J Gall OH Drummer 1997 J Forensic Sci 42 951 953
4. LP James K Abel J Wilkinson PM Simpson MH Nichols 2000 J Toxicol Clin Toxicol 38 615 623
5. D Harrison S Elliott 2001 Bull Int Assoc Forensic Toxicol 31 2 11 12
6. GK Isbister CR Balit HA Kilham 2005 Drug Safety 28 1029 1044
7. C Griffiths RJ Flanagan 2005 J Psychopharmacol 19 667 674
8. H Seno T Kumazawa A Ishii K Sato O Suzuki 1993 Jpn J Legal Med 47 367 371
9. M Pujadas S Pichini E Civit E Santamariña K Perez R de la Torre 2007 J Pharm Biomed Anal 44 594 601
10. Y Miyao A Suzuki K Noda H Noguchi 1983 J Chromatogr 275 443 449
11. K Hikida Y Inoue T Miyazaki N Kojima Y Ohkura 1989 J Chromatogr 495 227 234
12. T Kerbusch Z Desta NV Soukhova D Thacker DA Flockhart 1997 J Chromatogr B 694 163 168
13. S Walter S Bauer I Roots J Brockmöller 1998 J Chromatogr B 720 231 237
14. DW Hoffman RD Edkins 1994 Ther Drug Monit 16 504 508
15. HR Angelo A Petersen 2001 Ther Drug Monit 23 157 162
16. K Titier S Bouchet F Péhourcq N Moore M Molimard 2003 J Chromatogr B 788 179 185
17. N Yasui-Furukori Y Inoue M Chiba T Tateishi 2004 J Chromatogr B 805 175 180
18. HY Aboul-Enein I Ali H Hoenen 2006 Biomed Chromatogr 20 760 764
19. L Mercolini M Grillo C Bartoletti G Boncompagni MA Raggi 2007 Anal Bioanal Chem 388 235 243
20. C Kratzsch FT Peters T Kraemer AA Weber HH Maurer 2003 J Mass Spectrom 38 283 295
21. J Hempenius RJ Steenboorden FM Lagerwerf J Wieling JH Jonkman 1999 J Pharm Biomed Anal 20 889 898
22. H Seno H Hattori A Ishii T Kumazawa K Watanabe-Suzuki O Suzuki 2000 J Chromatogr B 746 3 9
23. R Eisert J Pawliszyn 1997 Anal Chem 69 3140 3147
24. H Kataoka S Narimatsu HL Lord J Pawliszyn 1999 Anal Chem 71 4237 4244
25. M Walles WM Mullett K Levsen J Borlak G Wünsch J Pawliszyn 2002 J Pharm Biomed Anal 30 307 319
26. H Kataoka HL Lord J Pawliszyn 1999 J Chromatogr B 731 353 359
27. Y Saito M Kawazoe M Hayashida K Jinno 2000 Analyst 125 807 809
28. MEC Queiroz EB Oliveira F Breton J Pawliszyn 2007 J Chromatogr A1174 72 77
29. BJG Silva FM Lanças MEC Queiroz 2008 J Chromatogr B 862 181 188
30. H Yuan Z Mester H Lord J Pawliszyn 2000 J Anal Toxicol 24 718 725
31. H Kataoka HL Lord J Pawliszyn 2000 J Anal Toxicol 24 257 265
32. Y Fan Y-Q Feng S-L Da X-P Gao 2004 Analyst 129 1065 1069
33. Y Fan Y-Q Fen S-L Da Z-H Wang 2005 Talanta 65 111 117
34. Kataoka H, Inoue R, Yagi K, Saito K (2009) J Pharm Biomed Anal 49:108-114
35. WM Mullett K Levsen D Lubda J Pawliszyn 2002 J Chromatogr A 963 325 334
36. J Wu H Lord J Pawliszyn 2001 Talanta 54 655 672
37. R King R Bonfiglio C Fernandez-Metzler C Miller-Stein T Olah 2000 J Am Soc Mass Spectrom 11 942 950
38. H Hattori T Arinobu M Iwai K Masuda O Suzuki H Seno 2005 Forensic Toxicol 23 13 17
39. M Schulz A Schmoldt 2003 Parmazie 58 447 474
40. Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, 2001. Available: http:// www.fda.gov/cder/guidance/4252fnl.htm
41. NC Hughes EYK Wong J Fan N Bajaj 2007 AAPS J 9 E353 E360
42. CT Viswanathan S Bansal B Booth AJ de Stefano MJ Rose J Sailstad VP Shah JP Skelly PG Swann R Weiner 2007 Pharm Res 24 1962 1973
43. I van den Broek RW Sparidans ADR Huitema JHM Schellens JH Beijnen 2006 J Chromatogr B 837 49 58